IRIS Accounts Production v26.1.0.640 04033745 director 1.8.24 31.7.25 31.7.25 false true false false false true false Ordinary shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh040337452024-07-31040337452025-07-31040337452024-08-012025-07-31040337452023-07-31040337452023-08-012024-07-31040337452024-07-3104033745ns15:EnglandWales2024-08-012025-07-3104033745ns14:PoundSterling2024-08-012025-07-3104033745ns10:Director12024-08-012025-07-3104033745ns10:PrivateLimitedCompanyLtd2024-08-012025-07-3104033745ns10:SmallEntities2024-08-012025-07-3104033745ns10:AuditExempt-NoAccountantsReport2024-08-012025-07-3104033745ns10:SmallCompaniesRegimeForDirectorsReport2024-08-012025-07-3104033745ns10:SmallCompaniesRegimeForAccounts2024-08-012025-07-3104033745ns10:FullAccounts2024-08-012025-07-310403374512024-08-012025-07-3104033745ns10:OrdinaryShareClass12024-08-012025-07-3104033745ns10:RegisteredOffice2024-08-012025-07-3104033745ns5:CurrentFinancialInstruments2025-07-3104033745ns5:CurrentFinancialInstruments2024-07-3104033745ns5:Non-currentFinancialInstruments2025-07-3104033745ns5:Non-currentFinancialInstruments2024-07-3104033745ns5:ShareCapital2025-07-3104033745ns5:ShareCapital2024-07-3104033745ns5:RetainedEarningsAccumulatedLosses2025-07-3104033745ns5:RetainedEarningsAccumulatedLosses2024-07-3104033745ns5:NetGoodwill2024-08-012025-07-3104033745ns5:IntangibleAssetsOtherThanGoodwill2024-08-012025-07-3104033745ns5:NetGoodwill2024-07-3104033745ns5:NetGoodwill2025-07-3104033745ns5:NetGoodwill2024-07-3104033745ns5:PlantMachinery2024-07-3104033745ns5:FurnitureFittings2024-07-3104033745ns5:ComputerEquipment2024-07-3104033745ns5:PlantMachinery2024-08-012025-07-3104033745ns5:FurnitureFittings2024-08-012025-07-3104033745ns5:ComputerEquipment2024-08-012025-07-3104033745ns5:PlantMachinery2025-07-3104033745ns5:FurnitureFittings2025-07-3104033745ns5:ComputerEquipment2025-07-3104033745ns5:PlantMachinery2024-07-3104033745ns5:FurnitureFittings2024-07-3104033745ns5:ComputerEquipment2024-07-3104033745ns5:CostValuation2024-07-3104033745ns5:WithinOneYearns5:CurrentFinancialInstruments2025-07-3104033745ns5:WithinOneYearns5:CurrentFinancialInstruments2024-07-3104033745ns10:OrdinaryShareClass12025-07-31
REGISTERED NUMBER: 04033745 (England and Wales)















Specialist Medicolegal Associates
Limited

Unaudited Financial Statements For The Year Ended 31 July 2025






Specialist Medicolegal Associates
Limited (Registered number: 04033745)






Contents of the Financial Statements
For The Year Ended 31 July 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Specialist Medicolegal Associates
Limited

Company Information
For The Year Ended 31 July 2025







DIRECTOR: B Cohen





REGISTERED OFFICE: 3 Coldbath Square
London
EC1R 5HL





REGISTERED NUMBER: 04033745 (England and Wales)





ACCOUNTANTS: Kingswood Allotts Limited
Chartered Accountants
Sidings Court
Lakeside
Doncaster
South Yorkshire
DN4 5NU

Specialist Medicolegal Associates
Limited (Registered number: 04033745)

Balance Sheet
31 July 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 34,384 35,868
Investments 6 100,918 100,918
135,302 136,786

CURRENT ASSETS
Debtors 7 115,575 58,873
Cash at bank 13,827 11,668
129,402 70,541
CREDITORS
Amounts falling due within one year 8 184,279 170,887
NET CURRENT LIABILITIES (54,877 ) (100,346 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

80,425

36,440

CREDITORS
Amounts falling due after more than one year 9 28,976 31,021
NET ASSETS 51,449 5,419

CAPITAL AND RESERVES
Called up share capital 10 400 400
Retained earnings 51,049 5,019
SHAREHOLDERS' FUNDS 51,449 5,419

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Specialist Medicolegal Associates
Limited (Registered number: 04033745)

Balance Sheet - continued
31 July 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 28 July 2026 and were signed by:





B Cohen - Director


Specialist Medicolegal Associates
Limited (Registered number: 04033745)

Notes to the Financial Statements
For The Year Ended 31 July 2025

1. STATUTORY INFORMATION

Specialist Medicolegal Associates Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
- the amount of revenue can be measured reliably;
- it is probable that the company will receive the consideration due under the contract;
- the stage of completion of the contract at the end of the reporting period can be measured reliably; and
- the costs incurred and the costs to complete the contract can be measured reliably.

Goodwill
Goodwill represents the difference between amounts paid on the cost of a business combination and the acquirers interest in the fair value of its identifiable assets and liabilities of the date of acquisition. Subsequent to initial recognition, goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised on a straight line basis to the Income Statement over its useful economic life.

Intangible assets
All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

Specialist Medicolegal Associates
Limited (Registered number: 04033745)

Notes to the Financial Statements - continued
For The Year Ended 31 July 2025

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery- not provided
Fixtures and fittings- 25% straight line
Computer equipment- 25% straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Income Statement.

Other fixed assets comprise artworks owned by the company. No depreciation is charged on these assets as it is the opinion of the director that these have an indefinite useful life. This is contrary to the Companies Act 2006 requirement for all fixed assets to be depreciated but is required in the opinion of the director to present true and fair financial statements.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Associates and joint ventures
Associates and Joint Ventures are held at cost less impairment.

Dividends
Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Specialist Medicolegal Associates
Limited (Registered number: 04033745)

Notes to the Financial Statements - continued
For The Year Ended 31 July 2025

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2024 - 5 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 August 2024
and 31 July 2025 510,200
AMORTISATION
At 1 August 2024
and 31 July 2025 510,200
NET BOOK VALUE
At 31 July 2025 -
At 31 July 2024 -

5. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 August 2024
and 31 July 2025 33,566 66,764 7,025 107,355
DEPRECIATION
At 1 August 2024 - 66,764 4,723 71,487
Charge for year - - 1,484 1,484
At 31 July 2025 - 66,764 6,207 72,971
NET BOOK VALUE
At 31 July 2025 33,566 - 818 34,384
At 31 July 2024 33,566 - 2,302 35,868

6. FIXED ASSET INVESTMENTS
Shares in
group
undertaking
£   
COST
At 1 August 2024
and 31 July 2025 100,918
NET BOOK VALUE
At 31 July 2025 100,918
At 31 July 2024 100,918

Specialist Medicolegal Associates
Limited (Registered number: 04033745)

Notes to the Financial Statements - continued
For The Year Ended 31 July 2025

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 38,075 58,873
Other debtors 77,500 -
115,575 58,873

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts 5,104 13,906
Taxation and social security 102,217 89,835
Other creditors 76,958 67,146
184,279 170,887

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2025 2024
£    £   
Bank loans 28,976 31,021

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
400 Ordinary shares £1 400 400

11. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The balance owing to B Cohen amounted to £14,463 (2024 - £4,287).

12. ULTIMATE CONTROLLING PARTY

The company was under the control of B Cohen by virtue of his majority holding of share capital of the company, throughout the year.